Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
6.93
-0.13 (-1.84%)
Oct 10, 2025, 2:45 PM EDT - Market open

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $299.69 million. The enterprise value is $95.23 million.

Market Cap299.69M
Enterprise Value 95.23M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

KYTX has 43.25 million shares outstanding. The number of shares has increased by 577.31% in one year.

Current Share Class 43.25M
Shares Outstanding 43.25M
Shares Change (YoY) +577.31%
Shares Change (QoQ) +0.02%
Owned by Insiders (%) 2.26%
Owned by Institutions (%) 25.99%
Float 22.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.66
P/TBV Ratio 1.63
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.03.

Current Ratio 5.39
Quick Ratio 5.32
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,769.37

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -91.92%
Revenue Per Employee n/a
Profits Per Employee -$1.42M
Employee Count112
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +54.10% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +54.10%
50-Day Moving Average 4.50
200-Day Moving Average 3.30
Relative Strength Index (RSI) 66.48
Average Volume (20 Days) 852,925

Short Selling Information

The latest short interest is 1.61 million, so 3.72% of the outstanding shares have been sold short.

Short Interest 1.61M
Short Previous Month 1.35M
Short % of Shares Out 3.72%
Short % of Float 7.16%
Short Ratio (days to cover) 5.85

Income Statement

Revenue n/a
Gross Profit -135.93M
Operating Income -171.63M
Pretax Income -158.70M
Net Income -158.70M
EBITDA -170.44M
EBIT -171.63M
Earnings Per Share (EPS) -$3.67
Full Income Statement

Balance Sheet

The company has $211.68 million in cash and $5.92 million in debt, giving a net cash position of $205.76 million or $4.76 per share.

Cash & Cash Equivalents 211.68M
Total Debt 5.92M
Net Cash 205.76M
Net Cash Per Share $4.76
Equity (Book Value) 184.38M
Book Value Per Share 4.26
Working Capital 174.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$141.41 million and capital expenditures -$638,000, giving a free cash flow of -$142.05 million.

Operating Cash Flow -141.41M
Capital Expenditures -638,000
Free Cash Flow -142.05M
FCF Per Share -$3.28
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -577.31%
Shareholder Yield -577.31%
Earnings Yield -52.73%
FCF Yield -47.19%

Analyst Forecast

The average price target for KYTX is $15.00, which is 116.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.00
Price Target Difference 116.45%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 2.48%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1